Bio-Thera Solutions, Ltd. (SHA:688177)
26.55
-0.54 (-1.99%)
At close: Oct 17, 2025
Bio-Thera Solutions Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | -398.39 | -510.3 | -394.53 | -480.4 | 81.94 | -513.23 | Upgrade |
Depreciation & Amortization | 90.23 | 87.86 | 85.24 | 83.84 | 72.94 | 58.98 | Upgrade |
Other Amortization | 3.34 | 2.18 | 0.11 | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -0.01 | 0.01 | -0.03 | -0 | - | 0.17 | Upgrade |
Asset Writedown & Restructuring Costs | -2.67 | -2.95 | -6.92 | 0.07 | 0.02 | - | Upgrade |
Loss (Gain) From Sale of Investments | 0.48 | -1.23 | -3.87 | -25.03 | -27.6 | -30.71 | Upgrade |
Provision & Write-off of Bad Debts | 0.18 | 0.23 | 0.19 | -0.71 | 0.9 | 0.1 | Upgrade |
Other Operating Activities | 22.47 | 20.86 | 11.78 | 0.63 | 0.69 | -0.07 | Upgrade |
Change in Accounts Receivable | 41.15 | 44.85 | -99.3 | 27.1 | 21.88 | -53.63 | Upgrade |
Change in Inventory | -43.82 | -21.87 | -69.33 | -71.8 | -44.47 | -2.35 | Upgrade |
Change in Accounts Payable | 293.83 | 299.37 | 41.14 | 53.48 | 129.99 | 182.69 | Upgrade |
Change in Other Net Operating Assets | - | 25.35 | -25.35 | - | - | - | Upgrade |
Operating Cash Flow | 6.79 | -55.65 | -460.87 | -412.82 | 236.27 | -358.04 | Upgrade |
Capital Expenditures | -116.2 | -126.85 | -262.14 | -258.82 | -77.89 | -253.27 | Upgrade |
Sale of Property, Plant & Equipment | 0.02 | 0 | 0 | 0.03 | 0 | 0 | Upgrade |
Investment in Securities | 210 | 240 | 288 | -28 | 340 | -940 | Upgrade |
Other Investing Activities | 3.54 | 5.49 | 11.71 | 40.99 | 39.65 | 15.82 | Upgrade |
Investing Cash Flow | 97.36 | 118.64 | 37.57 | -245.8 | 301.76 | -1,177 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 72.71 | Upgrade |
Long-Term Debt Issued | - | 378.93 | 441.85 | 3 | 30 | - | Upgrade |
Total Debt Issued | 310.29 | 378.93 | 441.85 | 3 | 30 | 72.71 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -174.16 | Upgrade |
Long-Term Debt Repaid | - | -277.73 | -34.97 | -32.99 | -2.91 | - | Upgrade |
Total Debt Repaid | -355.12 | -277.73 | -34.97 | -32.99 | -2.91 | -174.16 | Upgrade |
Net Debt Issued (Repaid) | -44.83 | 101.2 | 406.88 | -29.99 | 27.09 | -101.44 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 1,890 | Upgrade |
Common Dividends Paid | -22.57 | -20.6 | -9.32 | -0.16 | -0.55 | -3.85 | Upgrade |
Other Financing Activities | 8.62 | 6.69 | -2.4 | - | - | -5.25 | Upgrade |
Financing Cash Flow | -58.78 | 87.28 | 395.16 | -30.15 | 26.54 | 1,780 | Upgrade |
Foreign Exchange Rate Adjustments | 1.09 | 0.61 | 0.57 | 0.77 | -0.8 | -0.08 | Upgrade |
Net Cash Flow | 46.46 | 150.88 | -27.58 | -688 | 563.77 | 244.25 | Upgrade |
Free Cash Flow | -109.41 | -182.5 | -723.01 | -671.64 | 158.38 | -611.3 | Upgrade |
Free Cash Flow Margin | -13.98% | -24.56% | -102.58% | -147.57% | 18.93% | -334.30% | Upgrade |
Free Cash Flow Per Share | -0.26 | -0.44 | -1.74 | -1.62 | 0.39 | -1.51 | Upgrade |
Cash Income Tax Paid | 11.05 | 19.94 | -23.92 | -34.41 | -24.37 | -25.61 | Upgrade |
Levered Free Cash Flow | -28.42 | -108.15 | -591.18 | -510.64 | 34.74 | -532.3 | Upgrade |
Unlevered Free Cash Flow | -14.46 | -95.31 | -584.69 | -510.6 | 35.23 | -529.98 | Upgrade |
Change in Working Capital | 291.17 | 347.69 | -152.84 | 8.78 | 107.4 | 126.71 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.